Child Development Disorders, Pervasive
19
1
1
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
10.5%
2 terminated out of 19 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (19)
Arabic NODA Validation Study for Autism Diagnosis in Saudi Arabia
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
Effect of Problem-Solving Training
Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder
Using Mobile Technology to Reduce Stereotypy
Assessing Suicide Risk in Adolescents With Developmental Delays
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders
Randomized Trial of Parent Training for Young Children With Autism
Shared Decision Making to Improve Care and Outcomes for Children With Autism
A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
Mercury Chelation to Treat Autism
RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism